Extendicare Inc. (TSE:EXE – Get Free Report) shares hit a new 52-week high during mid-day trading on Thursday . The company traded as high as C$18.47 and last traded at C$18.44, with a volume of 672807 shares. The stock had previously closed at C$15.94.
Wall Street Analysts Forecast Growth
Several analysts recently commented on EXE shares. CIBC set a C$18.00 target price on Extendicare and gave the company an “outperform” rating in a report on Monday, September 22nd. National Bankshares boosted their price target on shares of Extendicare from C$16.10 to C$17.50 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a research note on Wednesday, July 16th. Finally, Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of C$15.20.
View Our Latest Stock Analysis on Extendicare
Extendicare Stock Performance
Extendicare Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 17th will be paid a $0.042 dividend. The ex-dividend date is Friday, October 31st. This represents a c) annualized dividend and a dividend yield of 2.7%. Extendicare’s payout ratio is currently 50.57%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- Do ETFs Pay Dividends? What You Need to Know
- Rare Earth Stocks: The Truce That Isn’t a Truce
- The Basics of Support and Resistance
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- 3 Healthcare Dividend Stocks to Buy
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
